S&P 500 7,676.77 +0.70%
Nasdaq 26,169.38 +0.82%
S&P/TSX 35,944.16 +0.44%
Apple 343.91 −1.10%
Nvidia 216.00 +2.39%
Microsoft 532.60 +1.54%
Shopify 235.93 −0.13%
Royal Bank 284.26 +0.88%
CAD/USD 0.7133 −0.05%
PRE-MKT · 08:45 ET
Market ClerkRecap
Tue Oct 27 · pre-market3 signals today140 insider buys this week · $73.9MCIRO short report next: Oct 31The week ahead
SM
INSIDER · RLMD · RELMADA THERAPEUTICS, INC. · CHIEF FINANCIAL OFFICER

Shenouda Maged

Every open-market transaction filed under this name, Sep 9 to Sep 10.

Filings
2
2 buys · 0 sells
Bought
$844K
open market, at cost
Sold
—
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 10RLMDRELMADA THERAPEUTICS, INC.Chief Financial OfficerBuy79,800$4.25$339K—
Sep 9RLMDRELMADA THERAPEUTICS, INC.Chief Financial OfficerBuy120,200$4.20$505K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.